Feasibility of Telesurveillance and Home Cough Assistance for Amyotrophic Lateral Patients (ALS)
The trial conducted by Fondazione Salvatore Maugeri aims to evaluate the feasibility of a structured telesurveillance program combined with home cough assistance for ALS patients. Given the increasing prevalence of ALS and the need for innovative home care solutions, this program could represent a significant advancement in patient management, potentially reducing hospitalizations and improving quality of life. The market for ALS therapies and supportive care is growing, with increasing interest from both pharmaceutical companies and healthcare providers. The successful implementation of this program may enhance the competitive positioning of the sponsor in the ALS care landscape, particularly in telemedicine and home healthcare sectors. Diligence implications include assessing the scalability of the program and its cost-effectiveness compared to traditional care models.
Indication: Amyotrophic Lateral Sclerosis
Modality: medical device
Target: Amyotrophic Lateral Sclerosis (ALS) management through telesurveillance and mechanical cough assistance.
Sponsor: Fondazione Salvatore Maugeri
Source URL: ClinicalTrials.gov
Source updated: Detailed source ingestion pending
Ingested: Jul 21, 2026
Model: trialsignal-ai-v1
Validation: validated
Matched by target_normalized: Amyotrophic Lateral Sclerosis (ALS) management through telesurveillance and mechanical cough assistance.
View original source fields
Condition raw: Amyotrophic Lateral Sclerosis
Condition normalized: Amyotrophic Lateral Sclerosis
Modality raw: medical device
Modality normalized: medical device
Target raw: Amyotrophic Lateral Sclerosis (ALS) management through telesurveillance and mechanical cough assistance.
Target normalized: Amyotrophic Lateral Sclerosis (ALS) management through telesurveillance and mechanical cough assistance.